Company Filing History:
Years Active: 2024
Title: Inventor Anneli Nordqvist: Pioneering Pharmaceutical Innovations
Introduction
Anneli Nordqvist is an accomplished inventor based in Gothenburg, Sweden. With her significant contributions to the field of pharmaceuticals, she has earned recognition for her innovative work. Notably, she holds one patent that reflects her expertise in developing novel compounds for medical applications.
Latest Patents
Anneli's patent focuses on N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides and their pharmaceutically acceptable salts. This invention involves compounds characterized by a specific formula that has promising applications in treating or preventing Prolyl endopeptidase fibroblast activation protein (FAP)-mediated conditions. Furthermore, her invention encompasses pharmaceutical compositions comprising these compounds, the use of such compounds in clinical applications, kits containing these compounds, and methods for their manufacturing.
Career Highlights
Throughout her career, Anneli has been associated with AstraZeneca AB, a global leader in pharmaceutical innovation. Her work at the company showcases her commitment to advancing medical science through the development of groundbreaking therapies. Anneli's expertise in medicinal chemistry and her innovative mindset have been pivotal in her endeavors.
Collaborations
In her journey as an inventor, Anneli has collaborated with several talented individuals, including her coworkers Jonas Brånalt and Maria Johansson. These collaborations foster an environment of creativity and ingenuity, allowing for the exchange of ideas and enhancing the development of innovative solutions in the field of pharmaceuticals.
Conclusion
Anneli Nordqvist exemplifies the spirit of innovation in the pharmaceutical industry. Her work and patent significantly contribute to the understanding and treatment of complex medical conditions. As a dedicated inventor, she continues to inspire future generations of scientists and inventors in their quest for innovative solutions.